Evidence map›Paper›PMID 39494290›Full record

ReviewPeerJ2024

Research progress on V delta 1

Yuxia Li, Yanfei Liu, Xiaoxiao Bu, Yuanyuan Qin, Yanyan Zhang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Development of αβ and γδ T Cells in the Thymus and Methods of Analysis.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuxia LiSchool of Basic Medical Sciences, Shandong Second Medical University, Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, Weifang, Shandong, China.
Yanfei LiuSchool of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong, China.
Xiaoxiao BuSchool of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong, China.
Yuanyuan QinSchool of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong, China.
Yanyan ZhangDepartment of Rheumatology and Immunology, Weifang Second People's Hospital, Weifang, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ongoing high occurrence of harmful infectious diseases significantly threatens human health. Existing methods used to control such diseases primarily involve targeting the pathogens, usually neglecting the vital role of host factors in disease advancement. Gamma delta (γδ) T cells act as a bridge between innate and adaptive immunity, playing a crucial role in combating pathogen invasion. Among these γδT cell subsets, which are categorized based on T cell receptor delta variable expression patterns, V delta (δ) 1

Indexed as

Receptors, Antigen, T-Cell, gamma-deltaAdaptive ImmunityAnimalsCell DifferentiationCommunicable DiseasesHumansImmunity, InnateInfectionsT-Lymphocyte SubsetsReceptors, Antigen, T-Cell, gamma-deltaCytokineDevelopmentMechanismPathogen infectionVδ1+ T cellsγδT cells

Identifiers

PMID39494290
PMCPMC11531252

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.